New Study Provides Hope For Multiple Sclerosis Patients

The results of a new clinical trial provides hope to people who suffer from multiple sclerosis, an autoimmune diseases which causes the immune system to mistake the central nervous system for something that needs to be attacked. The study subjected study participants to a high-dose immunosuppressive therapy. This was followed by transplanting the study participant’s own stem cells from their blood back into their bodies. This led to a sustained remission of their disease systems.

Almost 70% of the patients in the study showed no progression in their disease in the five years of the study. The symptoms of multiple sclerosis includes brain lesions, lethargy, pain, and speech and motor difficulties. The study as sponsored by the National Institute of Allergy and Infectious Diseases (NIAID). The NIAID is part of the National Institutes of Health. The study was carried out by the Immune Tolerance Network and published its findings in the peer-reviewed medical journal Neurology.

As a Neurologist and Psychiatrist, Dr. Shiva Gopal Vasishta has worked with many multiple sclerosis patients. He is excited by this new research and Dr. Shiva Gopal Vasishta thinks it shows a great deal of promise. He has been practicing medicine for almost 40 years after graduating from the Government Medical College in his native India.

Dr. Shiva Gopal Vasishta served his residency at Boston City Hospital soon after emigrating to the United States. He now practices medicine at Eastern Neurodiagnostics Associates in Voorhees, New Jersey.

As someone that is a Neurologist, Dr. Shiva Gopal Vasishta is very experienced in handling brain lesions in the multiple sclerosis patients he serves. He also uses his experience in psychiatry in order to help the patients deal with the emotional side of the disease that most suffer from.

Categories: Health
Jun
6

Leave a Reply